Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 47 Records) |
| Query Trace: Adenocarcinoma and CD4[original query] |
|---|
| Lung adenocarcinoma patients with KEAP1 mutation harboring low immune cell infiltration and low activity of immune environment. Thoracic cancer 2021 Jul . Cheng Wanwan, Xu Bin, Zhang Haitao, Fang Shenc |
| A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma. Oncogene 2021 Jun . Wu Jie, Li Lan, Zhang Huibo, Zhao Yaqi, Zhang Haohan, Wu Siyi, Xu B |
| Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma. Frontiers in oncology 2021 2 10 593022. Xu Jian-Zhao, Gong Chen, Xie Zheng-Fu, Zhao H |
| Clinical Impact of X-Ray Repair Cross-Complementary 1 (XRCC1) and the Immune Environment in Colorectal Adenoma-Carcinoma Pathway Progression. Journal of inflammation research 2021 11 14 5403-5417. Zhang Yu, Zhang Xin, Jin Zhuoyi, Chen Huiyan, Zhang Chenjing, Wang Wangyue, Jing Jiyong, Pan Wenshe |
| Distinct mutational profile and immune microenvironment in microsatellite-unstable and POLE-mutated tumors. Journal for immunotherapy of cancer 2021 10 9 (10): . Hwang Hee Sang, Kim Deokhoon, Choi Je |
| Differential Expression of the TLR4 Gene in Pan-Cancer and Its Related Mechanism. Frontiers in cell and developmental biology 2021 10 9 700661. Hu Jialing, Xu Jiasheng, Feng Xiaojin, Li Yiran, Hua Fuzhou, Xu Guoh |
| A novel prognostic index of stomach adenocarcinoma based on immunogenomic landscape analysis and immunotherapy options. Experimental and molecular pathology 2022 9 128 104832. Xue Weijie, Dong Bingzi, Wang Yixiu, Xie Yuwei, Li Pu, Gong Zhiqi, Niu Zhaoji |
| By characterizing metabolic and immune microenvironment reveal potential prognostic markers in the development of colorectal cancer. Frontiers in bioengineering and biotechnology 2022 8 10 822835. Liao Liangliang, Gao Yongjian, Su Jie, Feng |
| Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment. Lung cancer (Amsterdam, Netherlands) 2022 8 172 19-28. Akhave Neal, Zhang Jiexin, Bayley Erin, Frank Meredith, Chiou Shin-Heng, Behrens Carmen, Chen Runzhe, Hu Xin, Parra Edwin Roger, Lee Won-Chul, Swisher Stephen, Solis Luisa, Weissferdt Annikka, Moran Cesar, Kalhor Neda, Zhang Jianhua, Scheet Paul, Vaporciyan Ara A, Sepesi Boris, Gibbons Don L, Heymach John V, Lee Jack J, Wistuba Ignacio I, Andrew Futreal P, Zhang Jianjun, Fujimoto Junya, Reuben Alexand |
| An immune-related gene prognostic risk index for pancreatic adenocarcinoma. Frontiers in immunology 2022 8 13 945878. Su Yang, Qi Ruoshan, Li Lanying, Wang Xu, Li Sijin, Zhao Xuan, Hou Rui, Ma Wen, Liu Dan, Zheng Junnian, Shi Mi |
| Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma. Oncogenesis 2022 Jun 11 (1): 35. Qian Yunzhen, Gong Yitao, Zou Xuan, Liu Yu, Chen Yusheng, Wang Ruijie, Dai Zhengjie, Tasiheng Yesiboli, Lin Xuan, Wang Xu, Luo Guopei, Yu Xianjun, Cheng He, Liu Ch |
| Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2022 Jun . Liao Junqun, Ye Yuan, Xu Xur |
| Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types. Frontiers in molecular biosciences 2022 4 9 743515. Wu Yuliang, Huang Wei, Xie Yutong, Wang Chunyan, Luo Ning, Chen Yingying, Wang Liefu, Cheng Zhongping, Gao Zhengliang, Liu Shupe |
| Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma. Journal of oncology 2022 2022 9854788. Wen Chen-Yueh, Tsui Kuan-Hao, Chang Chiung-Hung, Chiu Yi-Han, Lin Shu-Chuan Amy, Chu Ching-Yu, Li Chia-Ju |
| A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with TP53 mutation. Translational cancer research 2022 2 10 (9): 3963-3978. Fu Jing, Li Yaonan, Li Cuidan, Tong Yuyang, Li Mengyuan, Cang Shundo |
| Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma. Translational cancer research 2022 2 10 (6): 2859-2872. Liu Libao, Xu Shilei, Huang Lei, He Jinyuan, Liu Gang, Ma Shaohong, Weng Yimin, Huang Shaoho |
| Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell Lung Cancer. Cancer control : journal of the Moffitt Cancer Center 0 29 10732748221076682. Feng Zhenxing, Yin Yan, Liu Bin, Zheng Yafang, Shi Dongsheng, Zhang Hong, Qin Jianw |
| Mutation of MUC16 Is Associated With Tumor Mutational Burden and Lymph Node Metastasis in Patients With Gastric Cancer. Frontiers in medicine 2022 9 836892. Zhang Fengxiang, Li Xianzhe, Chen Huaxian, Guo Jianping, Xiong Zhizhong, Yin Shi, Jin Longyang, Chen Xijie, Luo Dandong, Tang Haijie, Mao Chaobin, Lian L |
| Lactate regulators contribute to tumor microenvironment and predict prognosis in lung adenocarcinoma. Frontiers in immunology 2022 12 13 1024925. Shang Shipeng, Wang Mi-Zhou, Xing Zhiyuan, He Ningning, Li Shangyo |
| The Oncogenic and Immunological Roles of Apoptosis Antagonistic Transcription Factors in Human Tumors: A Pan-Cancer Analysis. Oxidative medicine and cellular longevity 2022 10 2022 3355365. Lu Feng, Wu Juan, Zou Hongpeng, Yang Xin, Wu Yongbing, Xu Jianj |
| The implication of necroptosis-related lncRNAs in orchestrating immune infiltration and predicting therapeutic efficacy in colon adenocarcinoma: an integrated bioinformatic analysis with preliminarily experimental validation. Frontiers in genetics 2023 8 14 1170640. Shizhe Li, Xiaotong Wang, Yajun Liu, Junbo Xiao, Jun |
| The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer. Gynecologic oncology 2023 6 175 133-141. Jin Li, Xiaohong Xue, Yan Zhang, Fengna Ding, Wenyan Wu, Cuicui Liu, Yang Xu, Hanlin Chen, Qiuxiang Ou, Yang Shao, Xinjun Li, Fei Wu, Xiaohua |
| Uses of Vascular Endothelial Growth Factor C as a Lung Adenocarcinoma Prognostic Biomarker. World journal of oncology 2023 3 14 (1): 51-59. Chen Shi, Pan Ting Yu, Wu Xiao, Li Tian, Wei Yu, He Hai Lang, Zhou Xian Mei, Wang Qian, Zhu Ji Pi |
| Development and Validation of a Prognosis-Prediction Signature for Patients with Lung Adenocarcinoma Based on 11 Telomere-Related Genes. Frontiers in bioscience (Landmark edition) 2023 11 28 (10): 254. Jia Liu, Sha Sha, Jian Wang, Xiaowei Gu, Menghua Du, Xu |
| CCR5 promoter polymorphisms associated with nonsmall cell lung cancer. International journal of immunogenetics 2023 11 . Tianchang Lu, Yuhan Shi, Minyi Wang, Weipeng Liu, Yang Cao, Li Shi, Qianli Ma, Shuyuan L |
| A Comprehensive Analysis of the Effects of Key Mitophagy Genes on the Progression and Prognosis of Lung Adenocarcinoma. Cancers 2023 1 15 (1): . Dai Dongjun, Liu Lihong, Guo Yinglu, Shui Yongjie, Wei Qich |
| Analysis of genomic and immune intratumor heterogeneity in linitis plastica via multiregional exome and T-cell receptor sequencing. Molecular oncology 2023 1 . Huang Jin, Zhao Guofeng, Peng Qiu, Yi Xin, Ji Liyan, Li Jing, Li Pansong, Guan Yanfang, Ge Jie, Chen Ling, Chen Runzhe, Hu Xin, Lee Won-Chul, Reuben Alexandre, Futreal P Andrew, Xia Xuefeng, Ma Jian, Zhang Jianjun, Chen Zih |
| Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterization. International journal of cancer 2024 9 . Fernando Gálvez-Montosa, Giulia Peduzzi, José Manuel Sanchez-Maldonado, Rob Ter Horst, Antonio J Cabrera-Serrano, Manuel Gentiluomo, Angelica Macauda, Natalia Luque, Pelin Ünal, Francisco Javier García-Verdejo, Yang Li, José Antonio López López, Angelika Stein, H Bas Bueno-de-Mesquita, Paolo Giorgio Arcidiacono, Dalila Luciola Zanette, Christoph Kahlert, Francesco Perri, Pavel Soucek, Renata Talar-Wojnarowska, George E Theodoropoulos, Jakob R Izbicki, Hussein Tamás, Hanneke Van Laarhoven, Gennaro Nappo, Maria Chiara Petrone, Martin Lovecek, Roel C H Vermeulen, Kestutis Adamonis, Fernando Jesus Reyes-Zurita, Bernd Holleczek, Jolanta Sumskiene, Beatrice Mohelníková-Ducho?ová, Rita T Lawlor, Raffaele Pezzilli, Mateus Nobrega Aoki, Claudio Pasquali, Vitalija Petrenkiene, Daniela Basso, Stefania Bunduc, Annalisa Comandatore, Hermann Brenner, Stefano Ermini, Giuseppe Vanella, Mara R Goetz, Livia Archibugi, Maurizio Lucchesi, Faik Guntac Uzunoglu, Olivier Busch, Anna Caterina Milanetto, Marta Puzzono, Juozas Kupcinskas, Luca Morelli, Cosimo Sperti, Silvia Carrara, Gabriele Capurso, Casper H J van Eijck, Martin Oliverius, Susanne Roth, Francesca Tavano, Rudolf Kaaks, Andrea Szentesi, Ludmila Vodickova, Claudio Luchini, Ben Schöttker, Stefano Landi, Orsolya Dohan, Matteo Tacelli, William Greenhalf, Maria Gazouli, John P Neoptolemos, Giulia Martina Cavestro, Ugo Boggi, Anna Latiano, Péter Hegyi, Laura Ginocchi, Mihai G Netea, Pedro Sánchez-Rovira, Federico Canzian, Daniele Campa, Juan Sai |
| Gut microbiota and pancreatic cancer risk, and the mediating role of immune cells and inflammatory cytokines: a Mendelian randomization study. Frontiers in immunology 2024 8 15 1408770. Zhiting Chen, Zhe Wang, Hejing Bao, Shudong |
| A study of the association of vitamin D receptor (VDR) as a predictive biomarker for immune checkpoint inhibitor therapy with immune invasion in colon adenocarcinoma. Journal of pharmaceutical and biomedical analysis 2024 10 252 116510. Guanqun Chao, Ailing Lin, Yang B |
- Page last reviewed:Feb 1, 2024
- Content source: